These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 33059299)

  • 1. The effect of COVID-19 lockdown on glycemic control in patients with type 2 diabetes mellitus in Turkey.
    Önmez A; Gamsızkan Z; Özdemir Ş; Kesikbaş E; Gökosmanoğlu F; Torun S; Cinemre H
    Diabetes Metab Syndr; 2020; 14(6):1963-1966. PubMed ID: 33059299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased stress, weight gain and less exercise in relation to glycemic control in people with type 1 and type 2 diabetes during the COVID-19 pandemic.
    Ruissen MM; Regeer H; Landstra CP; Schroijen M; Jazet I; Nijhoff MF; Pijl H; Ballieux BEPB; Dekkers O; Huisman SD; de Koning EJP
    BMJ Open Diabetes Res Care; 2021 Jan; 9(1):. PubMed ID: 33431602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of lockdown COVID-19 on metabolic control in type 2 diabetes mellitus and healthy people.
    Karatas S; Yesim T; Beysel S
    Prim Care Diabetes; 2021 Jun; 15(3):424-427. PubMed ID: 33441263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of lockdown for COVID-19 pandemic in Indian children and youth with type 1 diabetes from different socio-economic classes.
    Shah N; Karguppikar M; Bhor S; Ladkat D; Khadilkar V; Khadilkar A
    J Pediatr Endocrinol Metab; 2021 Feb; 34(2):217-223. PubMed ID: 33185578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of a prolonged lockdown and use of telemedicine on glycemic control in people with type 1 diabetes during the COVID-19 outbreak in Saudi Arabia.
    Alharthi SK; Alyusuf EY; Alguwaihes AM; Alfadda A; Al-Sofiani ME
    Diabetes Res Clin Pract; 2021 Mar; 173():108682. PubMed ID: 33539868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of COVID-19 pandemic on glycemic control among outpatients with type 2 diabetes in Japan: A hospital-based survey from a country without lockdown.
    Tanji Y; Sawada S; Watanabe T; Mita T; Kobayashi Y; Murakami T; Metoki H; Akai H
    Diabetes Res Clin Pract; 2021 Jun; 176():108840. PubMed ID: 33933499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preserved seasonal variation in glycemic control in patients with type 2 diabetes mellitus during COVID-19: a 3-year-long retrospective cohort study in older adults in Japan.
    Iwata S; Ashida K; Demiya M; Nagayama A; Hasuzawa N; Yoshinobu S; Sonezaki A; Yasuda J; Motomura S; Katsuki Y; Sugi K; Nomura M
    BMC Endocr Disord; 2024 May; 24(1):70. PubMed ID: 38755559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acceptability and Utilization of Newer Technologies and Effects on Glycemic Control in Type 2 Diabetes: Lessons Learned from Lockdown.
    Anjana RM; Pradeepa R; Deepa M; Jebarani S; Venkatesan U; Parvathi SJ; Balasubramanyam M; Radha V; Poongothai S; Sudha V; Shanthi Rani CS; Ranjani H; Amutha A; Manickam N; Unnikrishnan R; Mohan V
    Diabetes Technol Ther; 2020 Jul; 22(7):527-534. PubMed ID: 32522031
    [No Abstract]   [Full Text] [Related]  

  • 9. Weight change and glycemic control in type 2 diabetes patients during COVID-19 pandemic: the lockdown effect.
    Biamonte E; Pegoraro F; Carrone F; Facchi I; Favacchio G; Lania AG; Mazziotti G; Mirani M
    Endocrine; 2021 Jun; 72(3):604-610. PubMed ID: 33950348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycemic Control in Type 1 Diabetes Mellitus During COVID-19 Quarantine and the Role of In-Home Physical Activity.
    Tornese G; Ceconi V; Monasta L; Carletti C; Faleschini E; Barbi E
    Diabetes Technol Ther; 2020 Jun; 22(6):462-467. PubMed ID: 32421355
    [No Abstract]   [Full Text] [Related]  

  • 11. Status of Weight Change, Lifestyle Behaviors, Depression, Anxiety, and Diabetes Mellitus in a Cohort with Obesity during the COVID-19 Lockdown: Turk-Com Study Group.
    Yazıcı D; Fersahoğlu MM; Fersahoğlu T; Bulut NE; Çiğiltepe H; Çeler Ö; Sancak S; Sulu C; Durcan E; Şahin S; Polat Korkmaz Ö; Bozdoğan Polat SH; Taşkın E; İşeri C; Gürsoy E; Küçük Yetgin M; Kaya T; Özdemir F; Mestanoğlu İstanbullu N; Kıyıcı S; Öztürk S; Güngör K; Can B; Sargın M; Tabak Z; Averi S; Nazlı A; Polat Y; Akbas F; Tekin S; Topaloğlu Ö; Boz Uzaldı E; Çatalçam S; Bayraktaroğlu T; Çalıkoğlu BF; Nasifova V; Soyluk Selçukbiricik Ö; Karşıdağ K; Sezer H; Özışık S; Bulut H; Bekdemir B; Deyneli O; Dinçer C; Gogas Yavuz D; İlkova H; Yumuk VD
    Obes Facts; 2022; 15(4):528-539. PubMed ID: 35545017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the COVID-19 lockdown on glycaemic control in subjects with type 2 diabetes: the glycalock study.
    D'Onofrio L; Pieralice S; Maddaloni E; Mignogna C; Sterpetti S; Coraggio L; Luordi C; Guarisco G; Leto G; Leonetti F; Manfrini S; Buzzetti R
    Diabetes Obes Metab; 2021 Jul; 23(7):1624-1630. PubMed ID: 33764666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of COVID-19 Lockdown on Glycemic Control in Patients with Type 2 Diabetes Mellitus in Dubai.
    Makki I; Alnoon N; Rahmani N; Almulla J; Alamiri A; Alfalasi A; Zidan M
    Curr Diabetes Rev; 2022; 18(8):e081221198650. PubMed ID: 34879807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycemic parameters in patients with new-onset diabetes during COVID-19 pandemic are more severe than in patients with new-onset diabetes before the pandemic: NOD COVID India Study.
    Ghosh A; Anjana RM; Shanthi Rani CS; Jeba Rani S; Gupta R; Jha A; Gupta V; Kuchay MS; Luthra A; Durrani S; Dutta K; Tyagi K; Unnikrishnan R; Srivastava BK; Ramu M; Sastry NG; Gupta PK; Umasankari G; Jayashri R; Mohan V; Misra A
    Diabetes Metab Syndr; 2021; 15(1):215-220. PubMed ID: 33450530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of strict COVID-19 lockdown in Spain on glycemic profiles in patients with type 1 Diabetes prone to hypoglycemia using standalone continuous glucose monitoring.
    Mesa A; Viñals C; Pueyo I; Roca D; Vidal M; Giménez M; Conget I
    Diabetes Res Clin Pract; 2020 Sep; 167():108354. PubMed ID: 32739380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Observational study on Effect of Lock Down due to COVID 19 on glycemic control in patients with Diabetes: Experience from Central India.
    Khare J; Jindal S
    Diabetes Metab Syndr; 2020; 14(6):1571-1574. PubMed ID: 32858474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of telemedicine on glycemic control in type 2 diabetes mellitus during the COVID-19 lockdown period.
    Al-Mutairi AM; Alshabeeb MA; Abohelaika S; Alomar FA; Bidasee KR
    Front Endocrinol (Lausanne); 2023; 14():1068018. PubMed ID: 36817609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of nationwide lockdown during COVID-19 epidemic on lifestyle and other medical issues of patients with type 2 diabetes in north India.
    Ghosh A; Arora B; Gupta R; Anoop S; Misra A
    Diabetes Metab Syndr; 2020; 14(5):917-920. PubMed ID: 32574982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 pandemic: Effects of national lockdown on the state of health of patients with type 2 diabetes mellitus in a Moroccan population.
    Farhane H; Motrane M; Anaibar FE; Motrane A; Abeid SN; Harich N
    Prim Care Diabetes; 2021 Oct; 15(5):772-777. PubMed ID: 34172426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the COVID-19 lockdown on diabetes patients in Jeddah, Saudi Arabia.
    Alshareef R; Al Zahrani A; Alzahrani A; Ghandoura L
    Diabetes Metab Syndr; 2020; 14(5):1583-1587. PubMed ID: 32947759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.